RxDoctor Payments Data

Idelberto Badell, MD

Surgery · Atlanta, GANPI 1972787257

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,889 of the $26,585 with a category attached, or 89.9%. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 47.8% of the total. Among surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,585in general payments, 2019–2025

Across 15 payments — averaging $1772.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$13K
  • Veloxis Pharmaceuticals, Inc.$8K
  • E.r. Squibb & Sons, L.L.C.$4K
  • Intuitive Surgical$902
  • Medtronic$173
$3,885,174in research payments, 2019–2025

Across 10 payments — averaging $388,517 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$3.9M

What the payments were for

  • Consulting fees$23,88990%
  • Travel & lodging$1,3045%
  • Food & beverage$6432%
  • Education$7503%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,585 in reported general payments places this provider in the 90th percentile of 855 surgery providers in Georgia.

See all surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$73,948
Medicare patients
40
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl153$24,579
Envarsus XrTacrolimus21$21,912
Atovaquone32$12,995
Nifedipine ErNifedipine147$4,557
Mycophenolate Mofetil37$2,360
Nano 2nd Gen Pen NeedlePen Needle, Diabetic39$2,216
Humalog Kwikpen U-100Insulin Lispro18$2,053
Novolog FlexpenInsulin Aspart17$1,412
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim256$944
ValacyclovirValacyclovir Hcl21$607
Prednisone190$578
Atorvastatin Calcium190$533
Pantoprazole Sodium33$175
Carvedilol58$154
Hydralazine Hcl12$115

Paid to pharmacies, not to this prescriber.

Other surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →